TP53 and cancer: Li et al. determined that typical oncogenes and tumor suppressors for this cancer type included APC, KRAS, and TP53 [47], while Jung et al. discovered how DNA methylation and histone modifications and their inhibitors contributed to colon cancer formation and treatment [48].